Antibiotic Therapy in Infectious Diseases
A section of Antibiotics (ISSN 2079-6382).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Antibacterial Treatment in Periodontal and Endodontic Therapy, 2nd Volume (Deadline: 15 May 2024)
- Clinical Impact of Bacterial Resistance: Detection, Infection Control and Antimicrobial Stewardship Solutions (Deadline: 31 May 2024)
- Epidemiology, Diagnosis and Antimicrobial Treatment of Hospital-Acquired Infections (Deadline: 31 May 2024)
- Therapeutic and Microbiological Approaches for Combating Non-tuberculous Mycobacterial Infections (Deadline: 31 May 2024)
- Antimicrobial Therapy in Oral Diseases (Deadline: 31 May 2024)
- The Emergence of Drug-Resistant Staphylococcus aureus Infection and Recent Advances in Treatment Options (Deadline: 1 June 2024)
- Healthcare-Associated Infections (HAIs): Prevention, Control and Surveillance (Deadline: 15 June 2024)
- Present and Future of Antibiotic Treatment for Carbapenem-Resistant Enterobacteriaceae (Deadline: 20 June 2024)
- Carbapenemases in Gram-Negative Bacteria: A Global Health Threat and Therapeutic Challenge (Deadline: 30 June 2024)
- Optimizing Antibiotics Therapy for Combating Difficult-to-Treat Infections by Multidrug-Resistant Gram-Negative Bacteria (Deadline: 30 June 2024)
- Antimicrobial Treatment of Lower Respiratory Tract Infections (Deadline: 30 June 2024)
- Antibiotics and Infectious Respiratory Diseases, 2nd Volume (Deadline: 1 July 2024)
- Carbapenem Resistant Gram-Negative Pathogens—a Comprehensive Approach to Acinetobacter, Pseudomonas, Enterobacteriaceae, and Stenotrophomonas: A Global Healthcare Threat (Deadline: 15 July 2024)
- ‘Non-traditional’ Antimicrobial Approaches to Combat Antimicrobial Resistance (Deadline: 15 July 2024)
- Antibiotics in Ophthalmology Practice (Deadline: 15 July 2024)
- Feature Papers in Therapy of Diabetic Foot Infections (Deadline: 15 July 2024)
- Antimicrobial Resistance and Therapy in Intensive Care Unit (Deadline: 31 July 2024)
- Gastroenterology: The Pathogenic Potential of Mycobacterium paratuberculosis and Emerging Treatment Targets to Address Increasing Resistance (Deadline: 31 July 2024)
- A Themed Issue in Honor of Professor Robert A. Bonomo—Outstanding Contributions in the Fields of ß-Lactamase Inhibitors (Deadline: 31 July 2024)
- Evolution of Antimicrobial Resistance and Implications for Therapy in Respiratory Infections (Deadline: 31 July 2024)
- Approaches to Navigating Multi-Drug Resistance in Gram-Negative Pathogens (Deadline: 31 July 2024)
- Diagnosis and Antimicrobial Therapy of Osteoarticular Infection (Deadline: 31 July 2024)
- Antimicrobial Combination Therapy to Treat Difficult-to-Treat Infections: From Bench to the Bedside (Deadline: 15 August 2024)
- Bacteremia: Clinical Diagnostics and Epidemiology (Deadline: 15 August 2024)
- Antibiotics Prophylaxis for Knee Arthroplasty: Benefits and Problems, 2nd Edition (Deadline: 15 September 2024)
- Advancements in the Control and Diagnosis of Antimicrobial Resistance in Infectious Diseases (Deadline: 15 September 2024)
- Diagnosis and Treatment of Drug-Resistant Mycobacterium tuberculosis (Deadline: 15 September 2024)
- Emerging Topics in Clostridioides difficile Infection: A One Health Problem (Deadline: 20 September 2024)
- Epidemiology, Clinical Microbiology and Antimicrobial Therapy: A Shared Effort Against Infectious Diseases (Deadline: 20 September 2024)
- Surgical Infections and Sepsis: Epidemiology, Prevention and Antimicrobial Chemotherapy (Deadline: 30 September 2024)
- Infection Diagnostics and Antimicrobial Therapy for Critical Patient (Deadline: 30 September 2024)
- Epidemiology of Pathogens and Antimicrobial Resistance (Deadline: 30 September 2024)
- One-Stage Revision Arthroplasty: Local Antibacterial Implant Protection Techniques, Antibiotics, and Surgical Treatments (Deadline: 31 October 2024)
- Prevention and Antibiotic Treatment of Periprosthetic Joint Infection (Deadline: 31 October 2024)
- Pathogenesis, Diagnosis and Treatment of H. pylori Infection (Deadline: 31 October 2024)
- Infections in Immunocompromised Hosts and Antimicrobial Therapy (Deadline: 31 October 2024)
- Antimicrobial Therapeutics for Bone and Periprosthetic Joint Infection (Deadline: 31 October 2024)
- Therapeutic Handling of Infections Caused by Difficult-to-Treat Resistance (DTR) Gram-Negative Bacterial Pathogens: Is It Feasible? (Deadline: 18 November 2024)
- New Insights into Prevention, Diagnosis, and Treatment of Neonatal Sepsis and Short- and Long-Term Outcomes (Deadline: 31 December 2024)
- Infection and Treatment of Antibiotic-Resistant ESKAPE Pathogens (Deadline: 20 March 2025)